Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous 0.5% bupivacaine at skin incision for intraoperative hemodynamic changes
IRCT2016061024625N3Phase 3Completed
- Sponsor
- Vice-Chancellor for Research, Semnan University of Medical Sciences
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupivacaine in inguinal hernia, acute appendicitis and varicocele (2 arms), sponsored by Vice-Chancellor for Research, Semnan University of Medical Sciences. Primary endpoint: Intraoperative hemodynamic changes. Started Jan 2016; status: completed.
02
Drugs
bupivacaine
03
Conditions
inguinal herniaacute appendicitisvaricocele
Beyond the preview
Go deeper on IRCT2016061024625N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016061024625N3.